The HIGHEST GAINING Penny Stock for
|
The HIGHEST GAINING Penny Stock for Wednesday, April 04, 2012 is... |
Before we get started, quick shout out to Penny Buster for Monday's pick on HBRM.OB. We overlooked adding him to the Rumble. Congratulations on your winning pick!
For today, 365 emails were received and added to the Rumble today. After careful consideration of the end of day data, looking at BOTH dollar volume and percentage gain, we have made a decision on the winning penny stock of the day. The winner for the day is: EGPI Firecreek Inc. (EFIR.OB)
Last Trade: $0.0016 Price changed: $0.0007 Percentage Gain: 77.78 % Last Close: $0.0009 Volume: 181,480,816 Estimated Dollar Volume: $290,369.00
Congrats to Top Stock Pickers : OTC Picks. You are the King of the Stock Pickers today!
About EGPI Firecreek Inc. (EFIR.OB)
EGPI Firecreek, Inc. (EGPI) is an oil and gas production company focusing on the recovery and development of oil and natural gas. The Company focused on oil and gas activities for development of interests held in Texas and Wyoming for the production of oil and natural gas. On May 21, 2009, the Company acquired M3 Lighting, Inc. (M3). On November 4, 2009 the Company acquired South Atlantic Traffic Corporation (SATCO). On December 31, 2009, the Company's wholly owned subsidiary Energy Producers, Inc. acquired 50% interest in oil and gas leases, reserves, and equipment located in Shackelford, Callahan, and Stephens counties, West Central Texas. During the year ended December 31, 2009, the Company disposed of its wholly owned subsidiary Firecreek Petroleum, Inc. In February 2011, the Company acquired Arctic Solar Engineering, LLC. *************************
| HONORABLE MENTIONS: |
HIGHEST % GAIN: COMPANY: EFIR.OB % GAIN: 77.78% STOCK PICKER: OTC Picks |
HIGHEST $ VOLUME: COMPANY: SIRI $ VOLUME: 216,943,388.16 STOCK PICKER: The Momentum Traders Network |
** Follow Penny Stock Rumble ** ADD US TO YOUR GOOGLE PLUS!
|
|
Disclaimer
Acceptance of Terms and Investment Risk PENNYSTOCKRUMBLE.COM provides its service to you subject to the following Terms of Service ("TOS"), which may be updated by us from time to time without notice to you. By entering this site you agree to be bound by the Terms of Service (TOS). Information and opinions found on this website or published by PENNYSTOCKRUMBLE.COM , including web, email, print and video, are for informational and advertising purposes only. No statement or expression of opinion, nor any other matter herein, directly or indirectly, is an offer or the solicitation of any offer to buy or sell securities mentioned, nor any other securities. PENNYSTOCKRUMBLE.COM are not registered investment advisors. All visitors are advised to conduct their own independent rese
|
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Top 5 Most Recently Viewed Articles
Introduction to the New Battery Charger for Electric Vehicles In a world where electric vehicles (EVs) are becoming more prevalent, the quest for convenience and reliability in charging options has led to the creation of an exciting new product. An inventive mind has developed a portable battery charger designed specifically for electric cars, addressing the significant...
Continue Reading
The growth of the future value is not sufficient to invest in rental property, particularly in a market place such as Calgary where the economic cycles and population dynamics may affect the results. By computing the returns on the rental property, investors are able to know whether a property will be able to produce sustainable returns as they accumulate long te
Continue Reading
BioCardia's Anticipated Earnings Report BioCardia (NASDAQ: BCDA) is gearing up for its next quarterly earnings announcement. Investors are keen to hear the results as they look to gain insights into the company's performance and future expectations. Expected Earnings Per Share Current estimates suggest that BioCardia will report an earnings per share (EPS) of...
Continue Reading
President Trump's Impact During His Initial Month As President Trump's new term unfolds, impactful events are shaping his administration's direction. The first month has been marked by significant developments, highlighted by the Senate's confirmation of Kash Patel as the Director of the FBI. This move is seen as a pivotal moment, emphasizing a commitment to addressing...
Continue Reading
Eramet Revenue Decline in Q3 2025 Eramet has reported a decline in its adjusted turnover for the third quarter of 2025, which totaled €720 million. This marks a 10% decrease compared to the same quarter in 2024. The decrease primarily stems from significant external factors affecting sales and market conditions. Safety and CSR Achievements Despite facing a challenging...
Continue Reading